Funded Startups in Wuhan
Across these six Wuhan-based funded startups, the largest disclosed round is Newlas’ $14M Series A on 2025-11-06.
Across these six Wuhan-based funded startups, the largest disclosed round is Newlas’ $14M Series A on 2025-11-06. The remaining disclosed rounds cluster at $7M (Fuxin Technology Innovation on 2025-11-11 and Feiling Optoelectronics on 2025-09-10), making the $14M figure the only disclosed amount above the $7M level in this slice. Three entries carry undisclosed amounts (Detaina on 2025-09-26; Edgene Biot on 2025-09-23; Jijing Intelligent Technology on 2025-09-10), which limits comparisons but also stands out as a recurring gap.
Timing is concentrated: four of the six rounds fall between 2025-09-23 and 2025-11-11, with the most recent round dated 2025-11-11 (Fuxin Technology Innovation). Stage mix is skewed toward early rounds: Seed appears in four of six entries (Fuxin Technology Innovation, Feiling Optoelectronics, Edgene Biot, Jijing Intelligent Technology), alongside one Series A (Newlas) and one Series B (Detaina). Sector-wise, Automotive/Transportation-related themes recur across multiple companies (Newlas, Detaina, Jijing Intelligent Technology), alongside separate tracks in healthcare/AI (Fuxin Technology Innovation) and biotechnology/agriculture (Edgene Biot).
Most recent rounds
6 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Wuhan set, and how does it compare to other disclosed amounts?
Newlas’ $14M Series A (2025-11-06) is the largest disclosed amount shown; the only other disclosed figures are $7M rounds from Fuxin Technology Innovation (2025-11-11) and Feiling Optoelectronics (2025-09-10), so the top round is the only disclosed entry above the $7M level in these rows.
Are the funding rounds concentrated in a narrow recent time window?
Yes. Four of six rounds fall between 2025-09-23 and 2025-11-11, and the newest date in the table is 2025-11-11 (Fuxin Technology Innovation). By contrast, the oldest displayed round date is 2025-09-10 (Feiling Optoelectronics and Jijing Intelligent Technology), keeping the range tight within roughly two months.
How often are amounts undisclosed here, and does that create visibility gaps around any particular stage?
Undisclosed amounts appear in three of six entries: Detaina (2025-09-26, Series B), Edgene Biot (2025-09-23, Seed), and Jijing Intelligent Technology (2025-09-10, Seed). That means both early-stage (Seed) and a late stage shown (Series B) include undisclosed disclosures, not just one segment.
Does any stage dominate the Wuhan list?
Seed dominates this slice: four of six entries are classified as Seed (Fuxin Technology Innovation on 2025-11-11, Feiling Optoelectronics on 2025-09-10, Edgene Biot on 2025-09-23, and Jijing Intelligent Technology on 2025-09-10). The remaining two are evenly split by stage classification shown: one Series A (Newlas, 2025-11-06) and one Series B (Detaina, 2025-09-26).
Are there sector clusters or outliers worth flagging in Wuhan?
Automotive/transport themes recur across multiple entries (Newlas: Manufacturing/Automotive on 2025-11-06; Detaina: EV/Automotive/Energy/Transportation on 2025-09-26; Jijing Intelligent Technology: Automotive/Transportation on 2025-09-10). Meanwhile, healthcare/AI (Fuxin Technology Innovation, 2025-11-11; $7M) and biotechnology/agriculture (Edgene Biot, 2025-09-23; undisclosed) form narrower tracks that don’t repeat as frequently within these six rows.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.